Events

Global pharmaceutical supply chains are more integrated than ever. With its cost advantages and comprehensive industrial ecosystem, China has become a critical source of pharmaceutical inputs that underpin the US healthcare system and business operations in the life sciences sector. At the same time, China is emerging as a serious center for biotech innovation and novel drug development, adding a competitive dimension that goes beyond supply. Although this interdependence is well recognized, managing it requires greater coordination among policymakers, regulators, and industry stakeholders.

Join us for a timely briefing and roundtable discussion with the American Chamber of Commerce in Shanghai and The Asia Group.

We are excited to invite you to USCBC’s Shanghai edition of our China Operations Conference (CHOPs) 2026, our premier annual event in Shanghai, which will be held on November 3, 2026. Join us together with policy makers, business executives, and leading thinkers to share perspectives on how to maximize the American business community’s success and better navigate the increasing complexities of the China market. This year’s flagship event promises to be an insightful half-day of expert panel discussions covering critical topics including the China’s macroeconomy and its implications for US firms, evolving dynamics of US-China-EU relations, American companies’ role in China’s tech transformation, and other key issues that impact US businesses in China.